[go: up one dir, main page]

ZA9410197B - A method of treating gastrointestinal motility disorders - Google Patents

A method of treating gastrointestinal motility disorders

Info

Publication number
ZA9410197B
ZA9410197B ZA9410197A ZA9410197A ZA9410197B ZA 9410197 B ZA9410197 B ZA 9410197B ZA 9410197 A ZA9410197 A ZA 9410197A ZA 9410197 A ZA9410197 A ZA 9410197A ZA 9410197 B ZA9410197 B ZA 9410197B
Authority
ZA
South Africa
Prior art keywords
gastrointestinal motility
motility disorders
treating gastrointestinal
treating
disorders
Prior art date
Application number
ZA9410197A
Other languages
English (en)
Inventor
Beverley Greenwood
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA9410197B publication Critical patent/ZA9410197B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA9410197A 1993-12-21 1994-12-21 A method of treating gastrointestinal motility disorders ZA9410197B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17106093A 1993-12-21 1993-12-21

Publications (1)

Publication Number Publication Date
ZA9410197B true ZA9410197B (en) 1996-06-21

Family

ID=22622340

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9410197A ZA9410197B (en) 1993-12-21 1994-12-21 A method of treating gastrointestinal motility disorders

Country Status (9)

Country Link
US (1) US5744489A (fr)
EP (1) EP0732925A1 (fr)
JP (1) JPH09507843A (fr)
AU (1) AU1309995A (fr)
CA (1) CA2179491A1 (fr)
IL (1) IL112024A (fr)
TW (1) TW472055B (fr)
WO (1) WO1995017185A1 (fr)
ZA (1) ZA9410197B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565475A (en) * 1994-11-08 1996-10-15 Muhlhauser; Mark A. Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
EP0821954A1 (fr) * 1996-08-01 1998-02-04 Eli Lilly And Company Méthode de traitement d'arriération mentale
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
EP0821956A1 (fr) * 1996-08-01 1998-02-04 Eli Lilly And Company Méthode de traitement de troubles disruptifs de comportement
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
US20040023951A1 (en) * 2001-06-18 2004-02-05 Bymaster Franklin Porter Combination therapy for treatment of psychoses
PL2678332T3 (pl) 2011-02-25 2016-12-30 Pochodne diaminopirymidyny i sposoby ich wytwarzania
WO2021097427A1 (fr) 2019-11-15 2021-05-20 Karuna Therapeutics, Inc. Dérivés de xanoméline et méthodes de traitement de troubles neurologiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
IL112024A0 (en) 1995-03-15
AU1309995A (en) 1995-07-10
EP0732925A1 (fr) 1996-09-25
JPH09507843A (ja) 1997-08-12
IL112024A (en) 1999-07-14
TW472055B (en) 2002-01-11
US5744489A (en) 1998-04-28
CA2179491A1 (fr) 1995-06-29
WO1995017185A1 (fr) 1995-06-29

Similar Documents

Publication Publication Date Title
GB2289948B (en) Method of forming fine patterns
HU9600902D0 (en) Method of treating a metal surface
EP0729361A4 (fr) Procede de traitement de troubles neurologiques
GB9322845D0 (en) A method of treating a surface
IL112381A0 (en) A method of treating glaucoma
EP0423777A3 (en) Method of treating gastrointestinal motility disorders
ZA9410197B (en) A method of treating gastrointestinal motility disorders
PL313740A1 (en) Method of
ZA9410198B (en) A method of treating gastrointestinal motility disorders
ZA947751B (en) Method of treating septic shock using thymosin-alpha 1
GB9317920D0 (en) A method of treatment
GB2285201B (en) Timing recovery apparatus
GB9419133D0 (en) A method of forming sulphur
GB9313757D0 (en) A method of manufacturing a card
GB9200107D0 (en) A method of treating a surface
EP0752856A4 (fr) Procedes pour traiter l'hyperlipidemie
GB9312450D0 (en) Method of producing a pattern
PH31412A (en) Method of treating septic shock using thymosin-alpha 1.
GB9314636D0 (en) Novel treatment method
GB9326020D0 (en) Novel method of treatment
GB9308853D0 (en) Novel method of treatment
GB9303959D0 (en) Treatment method
GB9307004D0 (en) Method of treatment
GB9321796D0 (en) Method of treatment
GB9321971D0 (en) Method of treatment